Matches in DBpedia 2016-04 for { ?s ?p "Dacetuzumab (also known as SGN-40 or huS2C6) is a humanized monoclonal antibody being developed for the treatment of CD40-positive cancers like non-Hodgkin's lymphoma and hematological malignancies.This drug was developed by Seattle Genetics, Inc."@en }
Showing triples 1 to 4 of
4
with 100 triples per page.
- Dacetuzumab abstract "Dacetuzumab (also known as SGN-40 or huS2C6) is a humanized monoclonal antibody being developed for the treatment of CD40-positive cancers like non-Hodgkin's lymphoma and hematological malignancies.This drug was developed by Seattle Genetics, Inc.".
- Q953025 abstract "Dacetuzumab (also known as SGN-40 or huS2C6) is a humanized monoclonal antibody being developed for the treatment of CD40-positive cancers like non-Hodgkin's lymphoma and hematological malignancies.This drug was developed by Seattle Genetics, Inc.".
- Dacetuzumab comment "Dacetuzumab (also known as SGN-40 or huS2C6) is a humanized monoclonal antibody being developed for the treatment of CD40-positive cancers like non-Hodgkin's lymphoma and hematological malignancies.This drug was developed by Seattle Genetics, Inc.".
- Q953025 comment "Dacetuzumab (also known as SGN-40 or huS2C6) is a humanized monoclonal antibody being developed for the treatment of CD40-positive cancers like non-Hodgkin's lymphoma and hematological malignancies.This drug was developed by Seattle Genetics, Inc.".